Specific BAs including deoxycholic acid (DCA) and lithocholic acid (LCA) activate endothelial NF-κB and p38 MAPK signaling, inducing inflammatory responses and endothelial dysfunction. The gene discussed is NFKB1; the disease is endothelial dysfunction.